Inventor
BOBROWICZ PIOTR
US34 patents
⚠️ This page may combine multiple inventors who share the name “BOBROWICZ PIOTR”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BOBROWICZ PIOTR
8 patentsUS8445227B2May 21, 2013
N-acetylglucosaminyltransferase III expression in lower eukaryotes
BOBROWICZ PIOTR23 citations92
US8697394B2Apr 15, 2014
Production of modified glycoproteins having multiple antennary structures
BOBROWICZ PIOTR11 citations83
US8206949B2Jun 26, 2012
Production of glycoproteins with reduced O-glycosylation
BOBROWICZ PIOTR10 citations80
US9139632B2Sep 22, 2015
Method for producing proteins in Pichia pastoris that lack detectable cross binding activity to antibodies against host cell antigens
BOBROWICZ PIOTR5 citations69
US8795984B2Aug 5, 2014
Production of glycoproteins with reduced O-glycosylation
BOBROWICZ PIOTR1 citations59
US8501438B2Aug 6, 2013
Production of glycoproteins with reduced O-glycosylation
BOBROWICZ PIOTR3 citations59
US8158384B2Apr 17, 2012
Methods for reducing or eliminating α-mannosidase resistant glycans in the production of glycoproteins
BOBROWICZ PIOTR0 citations52
US8936918B2Jan 20, 2015
Yeast strain for the production of proteins with modified O-glycosylation
BOBROWICZ PIOTR1 citations50
COMPASS THERAPEUTICS LLC
8 patentsUS10716851B2Jul 21, 2020
Agonist antibodies that bind human CD137 and uses thereof
COMPASS THERAPEUTICS LLC10 citations91
US10350292B1Jul 16, 2019
Agonist antibodies that bind human CD137 and uses thereof
COMPASS THERAPEUTICS LLC12 citations91
US10279040B1May 7, 2019
Agonist antibodies that bind human CD137 and uses thereof
COMPASS THERAPEUTICS LLC10 citations91
US10279039B2May 7, 2019
Agonist antibodies that bind human CD137 and uses thereof
COMPASS THERAPEUTICS LLC10 citations91
US10279038B2May 7, 2019
Agonist antibodies that bind human CD137 and uses thereof
COMPASS THERAPEUTICS LLC11 citations91
US10434175B2Oct 8, 2019
Agonist antibodies that bind human CD137 and uses thereof
COMPASS THERAPEUTICS LLC5 citations82
US11752207B2Sep 12, 2023
Agonist antibodies that bind human CD137 and uses thereof
COMPASS THERAPEUTICS LLC0 citations61
US12460004B2Nov 4, 2025
Antibodies that bind CD277 and uses thereof
COMPASS THERAPEUTICS LLC0 citations51
GLYCOFI INC
7 patentsUS7449308B2Nov 11, 2008
Combinatorial DNA library for producing modified N-glycans in lower eukaryotes
GLYCOFI INC138 citations98
US7259007B2Aug 21, 2007
Methods for eliminating mannosylphosphorylation of glycans in the production of glycoproteins
GLYCOFI INC60 citations96
US7598055B2Oct 6, 2009
N-acetylglucosaminyltransferase III expression in lower eukaryotes
GLYCOFI INC41 citations95
US7465577B2Dec 16, 2008
Methods for reducing or eliminating α-mannosidase resistant glycans for the production of glycoproteins
GLYCOFI INC23 citations92
US7795002B2Sep 14, 2010
Production of galactosylated glycoproteins in lower eukaryotes
GLYCOFI INC29 citations89
US7713719B2May 11, 2010
Methods for reducing or eliminating α-mannosidase resistant glycans for the production of glycoproteins
GLYCOFI INC7 citations74
US7935513B2May 3, 2011
Combinatorial DNA library for producing modified N-glycans in lower eukaryotes
GLYCOFI INC5 citations73
GERNGROSS TILLMAN U
3 patentsUS8883483B2Nov 11, 2014
Combinatorial DNA library for producing modified N-glycans in lower eukaryotes
GERNGROSS TILLMAN U15 citations91
US8877462B2Nov 4, 2014
Combinatorial DNA library for producing modified N-glycans in lower eukaryotes
GERNGROSS TILLMAN U10 citations91
US8067551B2Nov 29, 2011
Combinatorial DNA library for producing modified N-glycans in lower eukaryotes
GERNGROSS TILLMAN U12 citations91
ADIMAB LLC
3 patentsUS10883997B2Jan 5, 2021
Polyspecificity reagents, methods for their preparation and use
ADIMAB LLC1 citations68
US10156574B2Dec 18, 2018
Polyspecificity reagents, methods for their preparation and use
ADIMAB LLC2 citations68
US12181480B2Dec 31, 2024
Polyspecificity reagents, methods for their preparation and use
ADIMAB LLC0 citations57